Trial Profile
A retrospective observational study of Pegylated Interferon-alpha 2a and Pegylated Interferon-alpha 2b in Chronic Hepatitis C
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Dec 2015
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Peginterferon alfa-2b (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Sponsors Merck & Co; Roche
- 30 Dec 2015 New trial record